The FDA approved the first drug to treat postpartum depression
On Tuesday, federal health regulators approved the first drug specifically designed to treat postpartum depression.
LEARN MOREFirst pill to treat postpartum depression could be available this year
The FDA is reviewing zuranolone, a 14-day oral treatment for adults with postpartum depression or major depressive disorder.
First pill to treat postpartum depression could be available this year
Seth Wenig / AP
February 8, 2023
The Food and Drug Administration is expected to reveal whether it has approved the first pill to treat postpartum depression later this year.
Zuranolone is a 14-day oral treatment for adults with postpartum depression or major depressive disorder.
"We see potential for zuranolone, if approved, to be a meaningful new option that can help address the serious unmet need faced by the diverse populations struggling with MDD and PPD," said Dr. Priya Singhal, executive vice president at Biogen, which partnered with Sage Therapeutics to develop the treatment.
The companies say the medication targets brain networks responsible for functions such as mood, arousal, behavior, and cognition.
Their application has been granted priority review and the FDA is expected to deliver a decision on Aug. 5.
Postpartum depression occurs after a woman gives birth. Symptoms include feelings of anger, thinking about hurting the baby, doubts about the ability to care for the child and withdrawing from loved ones.
According to the Centers for Disease Control and Prevention, about 1 in 8 women experience symptoms of postpartum depression.
"We feel a tremendous responsibility to patients with MDD and PPD to deliver a potential new treatment option, which is so desperately needed. Most current approved therapies may take weeks or months to work. We are committed to advancing treatments that could help physicians and patients by addressing depression symptoms quickly," said Dr. Laura Gault, chief medical officer at Sage.
2:52
Study: Black Americans adjust their behavior in health care settings
The study found one in four Black patients avoid health care settings for fears they will be treated unfairly.
Report finds 37% 'spike' in child poisoning deaths
Federal officials are highlighting a report during National Poison Prevention Week that showed an increase in child poisoning deaths.
Grindr offering free at-home HIV tests
Grindr has created a link on its app that allows users to order a free at-home HIV test.
Top Stories
10:24
Why does today's audience say certain fictional characters are gay?
In this segment of "Pop Quiz," Scripps News explores how historians and viewers are speculating about queer subtext in new and old media.
2:50
Los Angeles school support staff at an impasse in higher pay talks
Cafeteria workers, bus drivers and other school support staff employees say the district isn't meeting their requests.
3:01
This basketball magazine is mixing art with 'outlandish' sport stories
Flagrant Magazine is carving out its own space in the sports media industry by mixing abstract basketball art with culture stories from off the court.
